Search

Boswellia serrata and Boswellia sacra (syn. B. carteri) are important medicinal plants widely used for their content of bioactive lipophilic triterpenes. The qualitative and quantitative determination of boswellic acids (BAs) is important for their use in dietary supplements aimed to provide a support for osteoarthritic and inflammatory diseases. We used High Performance Liquid Chromatography (HPLC)-Diode Array Detector (DAD) coupled to ElectroSpray Ionization and tandem Mass Spectrometry (ESI-MS/MS) for the qualitative and quantitative determination of BAs extracted from the gum resins of B. sacra and B. serrata. Limit of detection (LOD), limit of quantification (LOQ), and Matrix Effect were assessed in order to validate quantitative data. Here we show that the BAs quantitative determination was 491.20 g·kg-1 d. wt (49%) in B. sacra and 295.25 g·kg-1 d. wt (30%) in B. serrata. Lower percentages of BAs content were obtained when BAs were expressed on the gum resin weight (29% and 16% for B. sacra and B. serrata, respectively). The content of Acetyl-11-Keto-β-Boswellic Acid (AKBA) was higher in B. sacra (70.81 g·kg-1 d. wt; 7%) than in B. serrata (7.35 g·kg-1 d. wt; 0.7%). Our results show that any claim of BAs content in either B. sacra or B. serrata gum resins equal to or higher than 70% or AKBA contents of 30% are simply unrealistic or based on a wrong quantitative determination. [ABSTRACT FROM AUTHOR]

Purpose: Urinary tract infections (UTIs) are widespread and affect a large portion of the human population. Cranberry juices and extracts have been used for UTI prevention due to their content of bioactive proanthocyanidins (PACs), particularly of the A type (PAC-A). Controversial clinical results obtained with cranberry are often due to a lack of precise determination and authentication of the PAC-A content. This study used Oximacro (Biosfered S.r.l., Turin, Italy), a cranberry extract with a high content of PAC-A, to prevent UTIs in female and male volunteers.Materials and Methods: The Oximacro PACs content was assayed using the Brunswick Laboratories 4-dimethylaminocinnamaldehyde (BL-DMAC) method, and the dimer and trimer PACs-A and PACs-B percentages were determined via high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS). A balanced group of female (ranging from 19 to over 51 years) and male volunteers (over 51 years) was divided into two groups. The experimental group received 1 capsule containing Oximacro (36 mg PACs-A) twice per day (morning and evening) for 7 days, and the placebo group was given the same number of capsules with no PACs.Results: Analysis of Oximacro revealed a high total PAC content (372.34 mg/g ± 2.3) and a high percentage of PAC-A dimers and trimers (86.72% ± 1.65). After 7 days of Oximacro administration, a significant difference was found between the placebo and Oximacro groups for both females (Mann-Whitney U-test = 875; P < .001; n = 60) and males (Mann-Whitney U-test = 24; P = .016; n = 10). When the female and male age ranges were analysed separately, the female age range 31-35 showed only slightly significant differences between the placebo and Oximacro groups (Mann-Whitney U-test = 20.5; P = .095; n = 10), whereas all other female age ranges showed highly significant differences between the placebo and Oximacro groups (Mann-Whitney U-test = 25; P = .008; n = 10). Furthermore, colony forming unit/mL counts from the urine cultures showed a significant difference (P < .001) between the experimental and the placebo groups (SD difference = 51688; df = 34, t = -10.27; Dunn-Sidak Adjusted P < .001, Bonferroni Adjusted P < .001).Conclusion: Careful determination of the total PAC content using the BL-DMAC method and the authentication of PACs-A with mass spectrometry in cranberry extracts are necessary to prepare effective doses for UTI prevention. A dose of 112 mg Oximacro containing 36 mg PACs-A was found to be effective in preventing UTIs when used twice per day for 7 days. [ABSTRACT FROM AUTHOR]

Salvia officinalis L. (Sage) is an important industrial plant used both for food and pharmaceutical purposes. The terpene fraction of this plant, which contains thujones and other mono and sesquiterpenoids, is responsible for many of its therapeutic and culinary properties. We used two extraction methods [hydrodistillation (HD) to obtain the essential oil (EO), and supercritical CO2 extraction (SFE)] to analyze by gas chromatography–mass spectrometry (GC–MS) the terpene fraction extracted from sage dried leaves. α-Thujone, β-thujone and other oxygenated monoterpenes (1,8-cineole, linalool, camphor, borneol and bornyl acetate) as well as hydrocarbon (β-caryophyllene and α-humulene) and oxygenated sesquiterpenes (caryophyllene oxide, viridiflorol, humulene epoxide II and III) were found. The EO contained a significantly (p < 0.05) higher percentage of 1,8-cineole (10.4%), α-thujone (17.3%) and camphor (29.2%), whereas supercritical fluid (SF) extracts contained a significantly higher percentage of borneol (8.4%), bornyl acetate (2.2%), α-humulene (6.4%), viridiflorol (22.1%), humulene epoxide II and III (2.4% and 0.4%), and some unidentified sesquiterpene alcohols. Both EO and SF extracts contained equal amounts of β-thujone (4.8%) and β-caryophyllene (~7%). Our results show that HD of EO is a more efficient and economic method for α- and β-thujone extraction. [ABSTRACT FROM AUTHOR]

Opuntia ficus indica (Opuntia) fruit has been shown to contain several bioavailable phytochemicals with effective anti-oxidative and antiinflammatory properties and, among these, the betalain pigment indicaxanthin. In the light of the strong interconnections between oxidative stress, inflammation and atherosclerosis, this work has evaluated the effects of a methanolic extract of Opuntia fruit (OFE), at nutritionally relevant concentrations, in an in vitro model of oxLDL-induced ED. [Extracted from the article]